Rising investments by public and private organizations in RD and decreasing costs of DNA sequences are some major factors driving market revenue growth 

The global genotyping assay market size is expected to reach USD 87.9 Billion in 2028 and register a revenue CAGR of 22.4%, according to the latest report by Reports and Data. Some key factors such as reduction in prices of DNA sequencing and increasing awareness about personalized medicine are factors driving global market revenue growth. 

Genotyping assay is a widely used method for determining DNA sequence and genetic composition by comparing it with other sequences. High efficiency, operational flexibility, and access to multiple parameters in a single testing are some essential features of modern genotyping assays. Market revenue growth is attributed to factors such as increasing funding by governments of various countries to support genotyping assay techniques, rising cases of chronic and genetic diseases across the globe, and high demand for these assays in research and educational institutes.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4827

The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.

Key companies operating in the market and profiled in the report include:

Thermo Fisher Scientific, Illumina, QIAGEN (Netherlands), Agilent Technologies, Danaher Corporation, Roche Diagnostics (Switzerland), GE Healthcare, Fluidigm Corporation, PerkinElmer, Eurofins Scientific (Luxembourg), Bio-Rad Laboratories, Pacific Biosciences of California, GENEWIZ, and Integrated DNA Technologies. 

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4827

The Genotyping Assay market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.

Segments Covered in the report

Product Service Outlook (Revenue, USD Billion, 2018 - 2028)

• Reagents Kits
• Genotyping Services
• Instruments
• Sequencers Amplifiers
• Analyzers
• Bioinformatics
• Software
• Services

Technology Outlook (Revenue, USD Billion, 2018 - 2028)

• PCR
• Real-time PCR
• Digital PCR
• Microarrays
• Sequencing
• NGS
• Pyrosequencing
• Sanger Sequencing
• Capillary Electrophoresis
• Amplified Fragment Length Polymorphism
• Restricted Fragment Length Polymorphism
• Single-stranded Conformation Polymorphism
• MALDI-TOF
• Other Technologies 
• Allele-specific Oligonucleotide (ASO) Probes
• Fluorescence In Situ Hybridization (FISH))

Application Outlook (Revenue, USD Billion, 2018 - 2028)

• Pharmacogenomics
• Diagnostic Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Other Applications 
• Prenatal Testing
• Human Forensics
• Microbial Genomic Studies
• Aquaculture Breeding Studies

End-Use Outlook (Revenue, USD Billion, 2018 - 2028)

• Pharmaceutical and Biopharmaceutical Companies
• Diagnostic and Research Laboratories
• Academic Institutes
• Other End-use 
• Animal and Aqua Genetics Companies
• Greenhouses
• Farms

Key Regions Analyzed in the Report include:

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• Italy
• France
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East Africa
• Saudi Arabia
• U.A.E.
• South Africa
• Rest of MEA

To know more about the report @ https://www.reportsanddata.com/press-release/global-genotyping-assay-market

Furthermore, it consists information about individual segment of the Genotyping Assay market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

Some Key Highlights from the Report:

• Based on product and service, the reagents and kits segment accounted for largest revenue share in 2020 and is expected to continue to contribute major revenue share over the forecast period. High demand for reagents and analysis kits is attributed to increasing research activities in the field of genotyping assay techniques, rising number of genotyping testing, and availability of new products. 
• Based on technology, sequencing segment is expected to account for substantially large revenue share during the forecast period, owing to factors such as advancements in genotyping assay technology, high demand for DNA sequencing, and growing adoption of NGS globally. 
• On the basis of end-use, the academic institutes segment is expected to register robust revenue CAGR throughout the forecast period, owing to rising funds provided by governments for research and increasing collaborations between major players and academic organizations for drug development. 
• North America is expected to account for largest revenue share in the global genotyping assay market during the forecast period, owing to presence of well-developed healthcare facilities, availability of funds for genotyping-based projects, and dominance of well-established market players. 
• Asia Pacific is expected to register a robust revenue CAGR throughout the forecast period, owing to increasing prevalence of chronic and genetic diseases, and growing awareness regarding importance of genotyping testing among people. Additionally, increasing trials and clinical research activities conducted by various pharmaceutical companies in countries in the region is expected to market revenue growth.  

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4827

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

Browse More Reports:

Phenylketonuria Market @ https://www.reportsanddata.com/report-detail/phenylketonuria-market

Intra Oral Scanners for Digital Impression Market @ https://www.reportsanddata.com/report-detail/intra-oral-scanners-for-digital-impression-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:        

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com